Gilead Sciences, Inc.
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
FY2009
FY2008
Asset Breakdown FY2024
Total Assets: $59.00B
Liabilities Breakdown FY2024
Total Liabilities: $39.67B
Asset Breakdown
Total Assets: $59.00B
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $9.99B | 16.9% |
| Accounts Receivable | $4.42B | 7.5% |
| Inventory | $1.71B | 2.9% |
| Property, Plant & Equipment | $5.41B | 9.2% |
| Goodwill | $8.31B | 14.1% |
| Intangible Assets | $19.95B | 33.8% |
| Other Assets | $9.20B | 15.6% |
Liabilities Breakdown
Total Liabilities: $39.67B
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $833.0M | 2.1% |
| Long-Term Debt | $24.90B | 62.8% |
| Other Liabilities | $13.94B | 35.1% |